3959-23-7

Basic information

• Product Name: (PHENYLSULPHONYL)ACETIC ACID
• Synonyms: RARECHEM AL BO 0222;(PHENYLSULPHONYL)ACETIC ACID;(PHENYLSULFONYL)ACETIC ACID;AKOS BC-3141;AKOS BBS-00002853;IFLAB-BB F2109-0039;2-(PHENYLSULFONYL)-ACETIC ACID;2-(Phenylsulphonyl)acetic acid
• CAS NO: 3959-23-7
• Molecular Formula: C₈H₈O₄S
• Molecular Weight: 200.21
• Mol File: 3959-23-7.mol
• Article Data: 55

Chemical Properties

• Melting Point: 112 °C
• Boiling Point: 452.2 °C at 760 mmHg
• Flash Point: 227.3 °C
• Appearance: /
• Density: 1.406 g/cm³
• Vapor Pressure: 5.77E-09mmHg at 25°C
• Refractive Index: 1.566
• PKA: pK1:2.44 (25°C)
• BRN: 2504376
• CAS DataBase Reference: (PHENYLSULPHONYL)ACETIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: (PHENYLSULPHONYL)ACETIC ACID(3959-23-7)
• EPA Substance Registry System: (PHENYLSULPHONYL)ACETIC ACID(3959-23-7)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 26-36
• HazardClass: IRRITANT
• Hazardous Substances Data: 3959-23-7(Hazardous Substances Data)

Usage

Uses

(Phenylsulfonyl)acetic acid is used as pharmaceutical intermediates.

InChI:InChI=1/C8H8O4S/c9-8(10)6-13(11,12)7-4-2-1-3-5-7/h1-5H,6H2,(H,9,10)

Upstream product

• 109-72-8 n-butyllithium 
• 3112-85-4 methylphenylsulfonate 
• 5296-64-0 allyl phenyl thioether 
• 64-19-7 acetic acid 
• 103-04-8 (phenylthio)acetic acid 
• 1360789-21-4 2-(phenylsulfonyl)-1-(2,2,6,6-tetramethylpiperidin-1-yl)ethanone 
• 108-98-5 thiophenol 
• 7722-84-1 dihydrogen peroxide 
• 93249-29-7 benzenesulfonylacetyl-urea 
• 71560-75-3 1,3-bis(benzenesulfonyl)propan-2-one 
• 20611-21-6 2-(phenylsulfonyl)ethanol 
• 7664-93-9 sulfuric acid 
• 873-55-2 sodium benzenesulfonate 
• 79-11-8 chloroacetic acid 

Downstream Products

• 129120-32-7 (E)-4-(2-(phenylsulfonyl)vinyl)pyridine 
• 92034-44-1 1-Butyl-3-phenylsulfonacetyl-harnstoff 
• 1360789-21-4 2-(phenylsulfonyl)-1-(2,2,6,6-tetramethylpiperidin-1-yl)ethanone 
• 1360789-13-4 N-(tert-butyl)-N-ethyl-2-(phenylsulfonyl)acetamide 
• 1360789-17-8 N-(tert-butyl)-N-isopropyl-2-(phenylsulfonyl)acetamide 
• 1360789-26-9 2-(phenylsulfonyl)-1-(2,2,6,6-tetramethylpiperidin-1-yl)propan-1-one 
• 118621-31-1 phenyl 2-(phenylsulfonyl)acetate 
• 1360789-25-8 S-phenyl 2-(phenylsulfonyl)ethanethioate 
• 34097-60-4 methyl benzenesulfonylacetate 
• 138336-33-1 tert-Butyl 2-(Phenylsulfonyl)acetate 
• 93249-25-3 N-(tert-butyl)-2-(phenylsulfonyl)acetamide 
• 93249-31-1 N,N-diisopropyl-2-(phenylsulfonyl)acetamide 
• 66074-00-8 3,4-bis(phenylsulfonyl)-1,2,5-oxadiazole 2-oxide 
• 70255-39-9 (E)-1-acetoxy-2-penten-5-yl benzenesulfonylacetate 

Relevant articles and documents

Discovery of β-carboline-(phenylsulfonyl)furoxan hybrids as potential anti-breast cancer agents

The cytotoxicity properties of the β-carboline alkaloids have been broadly investigated. However, the potential application of β-carbolines was hindered due to the moderate activity in cancer. In the present study, thirty β-carboline-(phenylsulfonyl)furoxan hybrids (11a–j, 12a–j and 13a–j) were designed and synthesized through esterification and amidation reaction strategy, and their inhibitory activities against the human breast cancer cell lines MCF-7 and MDA-MB-231 were evaluated by CCK-8 assay. Biological evaluation presented that the most promising amide derivative 13h, substituted with p-methoxyphenyl group at position 1, generated high concentration of NO and evidently depressed the MCF-7 (IC50 = 0.89 μM) and MDA-MB-231 (IC50 = 0.62 μM) cells proliferation. Particularly, the wound healing and transwell assays demonstrated that 13h significantly inhibited the migration and invasion of MDA-MB-231cells. Furthermore, the preliminary mechanisms studies indicated that 13h induced G2/M phase arrest and apoptosis possibly causing by ROS accumulation and ROS-mediated DNA damage. Based on these considerations, 13h may be a promising antimetastatic agent for breast cancer, which is noteworthy for further exploration.

Chromone 3-piperazine linked furazan derivative as well as preparation method and application thereof

The invention relates to the fields of natural medicines and medicinal chemistry, and relates to a preparation method of a series of chromone 3-piperazine linked furazan derivatives with antitumor activity and a new application of the chromone 3-piperazine linked furazan derivatives in preparation of antitumor medicines. The chromone 3-piperazine linked furazan derivative and the pharmaceutically acceptable salt thereof disclosed by the invention are as shown in a general formula I in the specification. Wherein R is described in the claims and the specification.

Chromone 2-piperazine linked furazan derivative as well as preparation method and application thereof

The invention relates to the fields of natural medicines and medicinal chemistry, and relates to a preparation method of a series of chromone 2-piperazine linked furazan derivatives with antitumor activity and a new application of the chromone 2-piperazine linked furazan derivatives in preparation of antitumor medicines. The chromone 2-piperazine linked furazan derivative and the pharmaceutically acceptable salt thereof disclosed by the invention are as shown in a general formula I in the specification. Wherein R is described in the claims and the specification.